Approval Timeline and Availability CagriSema: Ahead in the Race FDA Submission: December 18, 2025 (NDA filed) Expected FDA Decision: Q4 2026 or Q1 2027 Predicted Launch: Mid-2027 Advantage: 6-12 month head start on retatrutide REDEFINE Program Status: REDEFINE-1: Completed (obesity, 20.4% weight loss) REDEFINE-2: Completed (type 2 diabetes, 13.7% weight loss) REDEFINE-3: Ongoing (cardiovascular outcomes trial) REDEFINE-8: Ongoing (body composition study) High-dose CagriSema (2.4/7.2mg): Starting late 2026 Retatrutide: More Trials Needed FDA Submission: Expected Q4 2026 or Q1 2027 Expected FDA Decision: Late 2027 Predicted Launch: Q1-Q2 2028 TRIUMPH Program Status: TRIUMPH-4: Completed (osteoarthritis, 28.7% weight loss) TRIUMPH-1: Complete 28.3% weight loss (May 2026) TRIUMPH-2: Expected Q3Q4 2026 (obesity + type 2 diabetes) TRIUMPH-3: Expected later 2026 (obesity + cardiovascular disease) TRIUMPH-6: Weight maintenance trial (ongoing) Disadvantage: Needs more trials before submission, 6-12 month delay vs CagriSema
Vitamin B12 injections are given as a shot once a month
Members access detailed protocol builders, dosing calculators, combination therapy guidance, and a community of thousands of experienced researchers who have navigated these exact questions
Perfil de actividad documentada Pentadecapeptido gastrointestinal - secuencia de 15 aminoacidos (BPC) Evidencia preclnica predominante en modelos de tejido conectivo, tendon y musculo Revision Sikiric 2018 (Curr Neuropharmacol) - mecanismos documentados en modelo animal Estabilidad superior a peptidos de eje GH a temperatura ambiente Sin RCT humanos de gran escala publicados a la fecha Datos farmacolgicos documentados Mecanismo de accin Mecanismo multifactorial documentado en modelos animales: activacion de via NO-sintetasa, modulacion de VEGF (factor de crecimiento vascular), interaccion con receptores de hormona de crecimiento y proteccion de mucosa GI
Skipping this step can lead to issues if B12 levels arent where they need to be, resulting in potential side effects or a deficiency relapse
The rate at which the vitamin is absorbed is the primary distinction between B12 injections and infusions
